CAR-T at UCLA: Driving the Progress of Engineered Cell Therapy

Join UCLA hematologist, Dr. Sarah Larson, MD, for a discussion on the recently approved CAR-T cell therapy. She will focus on the latest research to improve the safety and efficacy of this promising therapeutic approach.